TY - JOUR AU - Lu, Shun AU - Zhou, Jian-Ying AU - Niu, Xiao-Min AU - Zhou, Jian-Ya AU - Jian, Hong AU - Yin, Hong-Yan AU - Guan, Sha AU - Wang, Lin-Fang AU - Li, Ke AU - He, James AU - Su, Wei-Guo PY - 2021 TI - Fruquintinib with gefitinib as first-line therapy in patients carrying EGFR mutations with advanced non-small cell lung cancer: a single-arm, phase II study JF - Translational Lung Cancer Research; Vol 10, No 2 (February 28, 2021): Translational Lung Cancer Research Y2 - 2021 KW - N2 - UR - https://tlcr.amegroups.org/article/view/48781